Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Clopidogrel in ACS Patients with Severe CKD (TROUPER)
NCT03357874Phase 3Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Oct 2018
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in acute coronary syndrome (ACS), sponsored by Assistance Publique-Hôpitaux de Marseille. Started Oct 2018; status: completed.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT03357874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03357874.